ProPhase Labs to Present at Two Upcoming August Conferences
August 16, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to...
ProPhase Labs to Host Second Quarter 2021 Financial Results Conference Call on Friday, August 13, 2021 at 11:00 a.m. Eastern Time
August 09, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY , Aug. 09, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, will hold a conference call on Friday, August 13, 2021...
ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021
July 12, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, July 12, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announced that Chief...
ProPhase Labs Added to the Russell Microcap Index
June 28, 2021 08:30 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, June 28, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase” or the “Company”), a diversified medical science and technology company, today announces that it has...
ProPhase Labs to Present at LD Micro Invitational XI Virtual Conference
May 28, 2021 08:30 ET
|
ProPhase Labs, Inc.
CEO Ted Karkus to Present at Conference on Thursday, June 10th, 2021 GARDEN CITY, NY, May 28, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and...
ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend
May 13, 2021 16:05 ET
|
ProPhase Labs, Inc.
First Quarter 2021 Revenue Increases 709% to $15.3 Million Driven by New Diagnostic Services Business Gross Profit Increases to $8.9 Million With Net Income of $1.1 Million or $0.07 Per Share ...
ProPhase Labs Partners With Dutchess County New York to Provide COVID-19 Testing
May 06, 2021 08:30 ET
|
ProPhase Labs, Inc.
State-Of-The-Art COVID-19 Testing Available for 300,000 Residents to Aid Reopening Efforts GARDEN CITY, NY, May 06, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified...
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020
November 16, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for...
ProPhase Labs Announces Definitive Agreement to Acquire CLIA Accredited Lab Certified for COVID-19 and Upper Respiratory Testing
October 23, 2020 08:30 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Oct. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today a definitive agreement to...
ProPhase Labs Reports Financial Results for the Year Ended December 31, 2019
March 25, 2020 08:36 ET
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, March 25, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced its net sales were $9.9 million for the year ended December 31,...